IBM INTERNATIONAL BUSINESS MACHINES CORP
Computer & office Equipment · NYSE · SEC CIK 51143 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.8%
TTM net income YoY41.3%
TTM EPS YoY40.2%
Revenue 3-yr CAGR4.5%
Net income 3-yr CAGR17.3%
Margins
Gross margin58.0%
Operating margin—
Net margin16.0%
FCF margin21.0%
EBITDA margin—
Returns
ROE35.2%
ROA7.4%
ROIC (approx.)—
Asset turnover0.46x
Leverage & solvency
Liabilities / assets76.6%
Debt / equity1.80x
Current ratio0.85x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.42x
Accruals ratio-3.1%
Payout ratio56.7%
Capex / revenue1.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $67.53B | $62.75B |
| Cost of revenue | $28.24B | $27.20B |
| Gross profit | $39.30B | $35.55B |
| R&D expense | $8.32B | $7.48B |
| SG&A expense | $20.12B | $19.69B |
| Interest expense | $1.94B | $1.71B |
| Pretax income | $10.33B | $5.80B |
| Income tax | -$242.00M | -$218.00M |
| Net income | $10.59B | $6.02B |
| EPS (basic) | 11.36 | 6.53 |
| EPS (diluted) | 11.17 | 6.43 |
| Dividends declared per share | 6.71 | 6.67 |
| Weighted avg. shares (diluted) | 948.68M | 937.16M |
| Balance sheet | ||
| Cash & equivalents | $13.59B | $14.16B |
| Receivables | $8.11B | $6.80B |
| Inventory | $1.22B | $1.29B |
| Current assets | $36.94B | $34.48B |
| PP&E, net | $5.90B | $5.73B |
| Goodwill | $67.72B | $60.71B |
| Intangibles | $11.39B | $10.66B |
| Total assets | $151.88B | $137.18B |
| Current liabilities | $38.66B | $33.14B |
| Short-term debt | $6.42B | $5.09B |
| Long-term debt | $54.84B | $49.88B |
| Total debt | $61.26B | $54.97B |
| Total liabilities | $119.14B | $109.78B |
| Shareholders' equity | $32.65B | $27.31B |
| Net debt | $47.67B | $40.81B |
| Shares outstanding | 936.95M | 926.29M |
| Cash flow statement | ||
| Operating cash flow | $13.19B | $13.45B |
| Capital expenditure | $1.09B | $1.05B |
| Free cash flow | $12.10B | $12.40B |
| Investing cash flow | -$10.30B | -$4.94B |
| Financing cash flow | -$3.83B | -$7.08B |
| Depreciation & amortization | $2.28B | $2.17B |
| Stock-based compensation | $1.72B | $1.31B |
| Dividends paid | $6.25B | $6.15B |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.